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We have studied effects of ferric transferrin (FeTF), ferric lactoferrin (FeLFI, ferric complexes of pyridoxal-or salicylaldehyde-isonicotinoyl hydrazone, (Fe-PIH, Fe-SIH), and ferric ammonium citrate (FAC) on expression of protein kinase C (PKC) mRNA transcripts in a variety of cultured cell lines. FeTF supported an increase of PKC-/3 mRNA transcripts in T-lymphoblastoid (CCRF-CEM; Jurkat), B-lymphoblastoid (Daudi; Raji), promyelocyte (HL-60), erythroleukemia (K562), and monocyte (U937) cell lines. By contrast, FeLF, Fe-PIH, and Fe-SIH did not support an increase of PKC-p mRNA transcripts in any of these cell lines. Furthermore, FAC supported an increase of PKC-p mRNA transcripts in HL-60, K562, and U937 cells only. Preincubation of cells with desferrioxamine (DF), a cell-permeable iron chelator, abolished the increments of PKC-p mRNA observed in response t o FeTF or FAC. In contrast t o results with PKC-p, neither FeTF nor FAC caused an increase of PKC-a transcripts in any cell line. To locate iron-responsive DNA regulatory elements of the PKCgene, we prepared genetic constructs containing various portions of the human PKC-p 5"flanking DNA linked t o the I RON IS AN ESSENTIAL element required by all cells for proliferation.' Iron is known to be required for activity of the critical enzyme, ribonucleotide reductase, but other potential mechanisms whereby iron may function to support cell proliferation are not well In many cell types, proliferation is coupled to protein kinase C (PKC)-dependent regulatory pathway^.^ At least 9 subspecies of PKC have been identified and designated a, PI, PII, y , 6, t, 6, v. and 0.4" Subtypes a and P are encoded by distinct genes located on human chromosomes 17 and 16, respectively, and both are expressed to varying degrees in hematopoietic cell^.^.^
We have shown previously that ferric transferrin (FeTF) supported PKC-P gene transcription, increased levels of firefly luciferase gene. Constructs were cotransfected with the neomycin resistance plasmid, Pwl-neo, into HRE H9 cells, and stable transfectants were selected in G418. Treatment with FeTF of transfectants bearing chimeric gene constructs with 2,200 bp of the PKC-p 5"flanking region increamd luciferase activity and mRNA transcripts 2.5-fold. This increase was blocked by DF. Neither luciferase activity nor mRNA increased with FeTF in stable transfectants bearing constructs with 342 bp or 587 bp of the PKC-p 5"flanking region. These data provide direct confirmation that iron is involved in regulation of PKC-p but not PKC-a gene expression in many cell lines. The form in which iron is presented t o these cell lines appears to affect its availability for this function, and cells vary in their capabilities t o use nontransferrin iron t o support PKC-p gene expression. Finally, transcriptional upregulation of PKC-p by FeTF is mediated by DNA sequences located between -2200 bp and -587 bp in the 5'-flanking region of the human PKC-/3 gene. This is a US government work. There are no restrictions on its use.
PKC-P mRNA, and increased PKC enzyme activity in the lymphoblastoid T-cell line, CCRF-CEM.R.9 This effect required iron delivery to the cells and was not mediated via a classic signal transduction pathway. x We now report that iron regulation of PKC gene expression is a characteristic of many hematopoietic cell lines. Induction of PKC-P gene expression by iron is highly dependent on the form in which iron is presented to a cell. The data also indicate that the PKC-fl subspecies is responsive to iron regulation, whereas the PKC-a subspecies is not. Finally, transfection experiments with PKC-P-luciferase gene constructs have been used to show that the 5'-flanking region of the human PKC-P gene contains iron-responsive transcriptional regulatory elements.
MATERIALS AND METHODS

Cell cultures.
The following cell lines were used in these experiments: T-lymphoblastoid, CCRF-CEM" and Jurkat"; B-lymphoblastoid, Daudi" and Raji"; promyelocytic, HL-60I4; erythroleukemia, K562I5; monocytic, U937"; and fibroblast (adenovirus type 5-transformed human embryonal kidney), 293. l7 Suspension cells in logarithmic growth phase were seeded in culture at 5 X IO4 to 1 X 105/mL in RPM 1-1 640 medium supplemented with 10% heatinactivated fetal bovine serum (FBS), 200 mmol/L L-glutamine, and antibiotics. Fibroblast cells, 293, were grown to confluence in Dulbecco's modified Eagle's medium supplemented with 10% heatinactivated FBS, L-glutamine, and antibiotics. The 293 cultures were split every 3 days.
For treatment with FeTF, ferric ammonium citrate (FAC), or ferric lactofenin (FeLF), plateau-phase cells were washed twice in one volume of ice-cold culture medium. The cells were resuspended in the same medium supplemented with 200 mmol/L L-glutamine, and 0.5% bovine serum albumin (BSA) at a concentration of 1 RNA hybridization analyses. Total cellular RNA was isolated by lysis in a guanidinium isothiocyanate solution and by pelleting through cesium chloride." Integrity of RNA was assessed by visualization of ethidium bromide-stained gels. For Northern analyses, total cellular RNA was electrophoresed through a 1% agarose gel containing formaldehyde. The gel was rinsed in water and 500 mL of l o x SSC (0.15 molL NaCI, 15 mmollL sodium citrate dihydrate) to remove formaldehyde; then RNA was transferred to nitrocellulose filters presoaked in 20X SSC. The filters were hybridized with "Poligolabeled cDNA probes. Hybridization was performed overnight in hybridization solution containing 50% formamide, 0.1% sodium dodecyl sulfate (SDS), 100 pg/mL sheared carrier DNA, 6X SSC, 2 x Denhardt's solution, and 10% dextran sulfate. After hybridization, the filters were washed for 10 minutes each in 3 changes of 2 x SSC and 0.1% SDS and in 2 changes of 0.2% SSC and 0.1% SDS (45"C, 1 hour). After washing, filters were exposed to Kodak X-OMAT film (Eastman-Kodak, Rochester, NY) at -70°C with Dupont Cronex intensifying screens (Dupont, Wilmington, DE). Relative intensities of autoradiographs were determined by scanning densitometry.
Oligonucleotide probes. Probes used were PKC-a, 2.0-and I .25-kb Pst I fragments from the bovine phPKC-a 7 clone7,*'; PKC-0, 4. I-and 0.68-kb Pst I fragments from the bovine phPKC-P 1-I5-Eco clone6; and a-actin, a 3.8-kb EcoRI-Hind111 fragment from the human a-actin genomic clone, HA4.'* Promoter constructs. Obeid et alZ3 cloned the 5'-terminal region of the human PKC-P gene from a human genomic library in EMBL-3 and determined the coding sequence for 559 bp of the 5"flanking region.23 Promoter constructs were made using the promoterless luciferase vector pSVOA that was provided by Dr Suresh Subramani (University of California, San Diego, CA).24 Constructs are depicted schematically in Fig 1. Construct no. 1 is an EcoRVMae I11 fragment spanning 371 bp of the 5' region of PKC-P. This was cloned into the HindiII s~te of pSVOA in front of the luciferase reporter gene by using HindIII linkers. Constructs no. 2 and 3 were produced by polymerase chain reaction (PCR) cloning using oligonucleotides homologous to the 5' region of the PKC-P gene. These constructs were subcloned into the HindIII site of pSVOA by inserting Hind111 sites at the 3' ends of the PCR oligonucleotides. Orientation was verified by restriction-mapping or sequencing. Polymerase chain reaction-generated construct no. 2 was sequenced, and construct no. 3 was verified by restriction-mapping and partial sequencing.
Transfection experiments. HRE H9 cells were transfected using the CaPO, method.2s For transfections. 15 pg of cesium chloride gradient-purified plasmids were used. The neomycin-resistant plasmid, PWL neo (Stratagene, LaJolla, CA), was cotransfected with PKC-P-luciferase plasmids at a 1:3 ratio. Cells were exposed for 12 hours to the CaPO,/DNA precipitate, washed, incubated with fresh media supplemented with 10% FBS for 48 hours, and then treated with G418 (400 &rL) for 30 days before beginnlng the following experiments.
To test the effect of iron on luciferase expression by stable transfectants, transfected cells in iOO-mnl dishes were incubated for 48 hours at 37°C and 5% COz in a-minimum essential medium containing 10% heat-inactivated FBS. FeTF (100 pg/ml), with or without DF (50 pm/L), was included in certain cultures. After incubation, cells were lysed using a Triton X-100-based lysis reagent for measurement of luciferase activity, or cells were harvested for extraction of mRNA.
Luciferase activity in lysates was measured with the Promega (Madison, WI) Assay System using 20 pL of lysate in a Turner TD20e luminometer (Turner Designs, Mountain View, CA) for 20 S of integrated time. To detect luciferase mRNA, Northern blots were probed with 32P-oligolabeled linearized plasmids or luciferase cDNA excised from pSVOA by EcoRI.
FeTF binding studies and measurement of cellularferririn content. Radioligand binding studies were performed as we have previously described.z6 Iron-saturated human FeTF was radiolabeled with '"I by the chloramine-T method and then incubated with HRE H9 cells in medium containing 0.5% BSA for 90 minutes at 4°C. Parallel reactions to correct for nonspecific binding included more than 200-fold excess of unlabeled FeTF. Reactions were terminated wlth cold phosphate-buffered saline, and cells were collected by filtration on Whatman (Maidstone, UK) GF/C glass fiber filters. Specific binding was taken as the difference in counts per minute bound between parailei reactions lacking or including unlabeled FeTF. Data were analyzed by the method of Scatchard.*' Ferritin content of whole cell lysates was determined using the Becton Dickinson femtin monoclonal antibody solid-phase component system (Becton Dickinson CO, Orangeburg, NY). same cell lines. Therefore, we have examined the effect of FeTF on PKC-P and PKC-a mRNA transcripts in seven hematopoietic cell lines representative of T and B lymphocytes, promyelocytes, monocytes, and erythroleukemia cells. A single nonhematopoietic cell line, 293, also was studied. Results are shown in Fig 2. In each hematopoietic cell line, FeTF supported a threefold to fivefold increase in steady state level of PKC-P mRNA transcripts after 60 minutes. This increase was abolished by preincubation of cells with DF, indicating that the effect was dependent on delivery of Fe3+ (Fig 3) . Ferrioxamine had no effect (data not shown).x We have previously shown that the increase of PKC-P mRNA transcripts induced by exposure to FeTF was sustained up to 72 hours.* In contrast to the results given by each hematopoietic cell line, no increase of PKC-P mRNA transcripts was observed in the fibroblast line, 293, when treated under identical conditions or when exposed to FeTF for up to 24 hours (data not shown).
RESULTS
Effect
All eight cell lines used for these experiments expressed both PKC-P and PKC-a isoforms (Fig 2) , thereby permitting additional experiments to test effects of FeTF on PKC-a mRNA transcripts. No increase of PKC-a transcripts was observed in any of the cell lines after exposure to FeTF for up to 48 hours. These data indicate that the PKC-a and -P genes differ in their susceptibilities to regulation by FeTF.
Effect of treatment with other iron compounds on PKC-P and PKC-a mRNA transcripts. Previously, we had observed that FAC did not produce an increase of PKC-0 mRNA transcripts in CEM cells.x Results of treating various other hematopoietic cell lines with FAC (75 pmol/L) are shown in Fig 2B. No increase of PKC-0 mRNA transcripts was observed in T-or B-lymphoblastoid cell lines when treated with FAC under the standard experimental conditions or for 24 hours. By contrast, in the nonlymphoid hematopoietic cell lines (HL-60, K562, and U937). FAC induced a twofold to fourfold increase in steady state level of PKC-P transcripts after 60 minutes. DF again abolished this effect (Fig 3) . FAC did not induce an increase of PKC-P transcripts in the fibroblast line, 293, after I or 24 hours. Also, FAC did not cause an increase of PKC-a transcripts in any of the seven hematopoietic cell lines. These data indicate that differences exist between these lymphoid and nonlymphoid hematopoietic cell lines with respect to their abilities to use nontransferrin iron for regulating PKC-P expression. In addition, they indicate that PKC-a differs from PKC-0 in its absence of regulation by iron delivered either as FeTF or FAC.
The different effects on PKC-P transcripts observed in some cell lines with FeTF and FAC suggested that the route by which iron is delivered to a cell may effect the subsequent use of the metal. To examine further the influence of the route by which iron is presented, we examined effects of FeLF and of Fe-PIH and Fe-SIH on PKC-P mRNA transcripts by these cell lines. FeLF, Fe-PIH, and Fe-SIH did not support an increase of PKC-P mRNA transcripts in any of the cell lines during incubations of I , 24, or 48 hours. Representative results for some cell lines are presented in Fig 4. We measured cellular ferritin levels in cells before and 48 hours after treatment with Fe-PIH and Fe-SIH (Table  l ) . With the exception of the Daudi cell line, ferritin levels increased significantly indicating that iron delivered by these complexes was taken into the cells. These data lend additional support to the observations with FeTF and FAC (Fig lanes 1 and 3) or CCRF-CEM (lanes 2 and 4) cells were incubated with FeTF or ferric ammonium citrate, each with or without DF, for 60 minutes under conditions described in Materials and Methods. After extraction of total cellular RNA, blot hybridization was performed using PKC-P (lanes 1 and 2) or a-actin (lanes 3 and 4) 
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2) that the form in which iron is presented to cells influences the subsequent use of that iron for various cellular functions. In this case, cells are unable to use ferric iron presented as either FeLF, Fe-PIH, or Fe-SIH to regulate expression of PKC-P. By contrast, cells are able to use ferric iron presented as FeTF for this purpose, and some cells, notably HL60, K562, and U937 cell lines, also are able to use femc iron presented as FAC for a similar function.
Development of stable transfectants expressing PKC-P-
luciferase fusion genes. The tartrate-resistant acid phosphatase (TRAP) gene is transcriptionally regulated by FeTF in a manner similar to that for PKC-p? 8 We previously have used the cell line HRE H929 to stably express murine TRAPluciferase gene constmcts and to study their response to FeTF.2R These experiments showed the presence of ironresponsive DNA sequences in the 5"flanking region of the mouse TRAP gene. Therefore, HRE H9 cells were chosen to develop stable transfectants expressing human PKC-pluciferase gene constructs composed of various segments of the PKC-P 5"flanking region (Fig 1) . Stable transfectants bearing the various constructs (shown in Fig 1) or the promoterless plasmid, pSVOA, were cultured, and luciferase activity in logarithmically growing cultures was determined. Results, shown in Fig 5, indicate that all 3 fragments of the human PKC-P 5"flanking region were capable of driving the luciferase reporter gene. The two larger fragments were more efficient than the shorter, but these, in turn, were only 10% as efficient as the SV40 promoter. Table 2 . These data indicate that luciferase mRNA transcripts consistently were increased by FeTF in transfectants bearing construct no. 3 and that this increase was blocked by DF. Taken together, the results of the transfection experiments indicate that the effect of FeTF is mediated via the PKC-P 5"flanking region and is dependent on the intracellular delivery of iron. Furthermore, it appears that DNA sequences located between -2,200 bp and -587 bp are most important for this iron regulation.
DISCUSSION
These studies expand on our previous observation that PKC-P gene transcription was supported in CCRF-CEM cells by iron delivered as FeTF.* In those studies, nuclear run-on assays showed a sevenfold increase in the rate of PKC-P gene transcription within 3 hours of treatment with FeTF. Increase of gene transcription was associated with sustained (up to 72 hours) steady state levels of PKC-P 2.5 - I mRNA transcripts and increase of both PKC enzyme activity and phorbol dibutyrate binding. The requirement for iron in this regulation was established by showing that DF but not ferrioxamine abolished the FeTF-stimulated increase of PKC-P transcripts and that neither gallium transferrin nor apo-transferrin supported a similar increase. We now have shown that six other human hematopoietic cell lines, both lymphoblastoid and nonlymphoblastoid, show a similar capability to use iron from FeTF to support an increase of PKC-P mRNA transcripts (Figs 2 and 3) . The fact that the fibroblast line, 293, did not show such a response indicates that not all cell types are capable of using transferrin iron in this capacity. It is of interest that all seven hematopoietic cell lines, including T (CCRF-CEM, Jurkat) and B (Daudi, Raji) lymphoblastoid, erythroleukemia (K562), monocyte (U937), and promyelocyte (HL-60). do possess this capacity. However, this capacity is not limited to hematopoietic cells because the HRE H9 rabbit endometrial cell line used for transfections used transferrin iron for gene regulation (Figs 6, 7, and 8) .
It is of considerable further interest that, unlike PKC-P, expression of the PKC-a gene was not regulated by iron in any cell line examined (Fig 2) . This differential regulation of An additional observation from these studies is that not all iron delivered to cells becomes available for regulation of PKC-P expression and. further, that cells differ in their abilities to use nontransferrin iron for this function (Figs 2  and 4) . Thus nonlymphoblastoid cell lines, K562, HL-60, and U937, responded to treatment with FAC by increases of PKC-P mRNA transcripts, whereas lymphoblastoid cell lines did not (Fig 2) . Because this pattern of response to FAC was observed consistently on repeated occasions, we do not believe that the different responses of different cell lines to FAC reflect an artifact caused by unreliable solubility of FAC. We have shown previously that treatment of CCRF-CEM cells with FeTF or FAC resulted in equivalent whole cell increases in ferritin, indicating that uptake of iron occurred from either compound. ' None of the cell lines tested used iron from FeLF or from the ferric complexes. Fe-PIH or Fe-SIH, to increase PKC-P mRNA transcripts (Fig 4) . Data indicate that FeTF and FeLF bind to separate receptors?" and suggest that, unlike FeTF, FeLF may not serve as an efficient iron donor to intracellular pools.."." Nonetheless, FeLF effectively may support cell It has been suggested that FeLF may mimic the effects of certain impermeable membrane oxidants that are believed to stimulate serum-free cell growth by activating plasma membrane oxidase and Na'/H' antiport activity:" Recently, a similar mechanism for FeTF in supporting cell growth has been proposed." The observation that FeLF did not stimulate an increase of PKC-P mRNA transcripts in any cell line may be taken as support that iron does not activate PKC-P gene expression by stimulating plasma membrane oxidoreductase activity.
Fe-PIH and Fe-SIH.'' have been shown to support transferrin-independent iron uptake and utilization in a variety of in vitro systems." Of particular relevance to this study are the observations that Fe-PIH may support transferrin-inde- (Fig 4) , despite increased iron uptake as measured by cellular ferritin content (Table 1) . Taken together, the data from experiments with FAC, FeLF, Fe-PIH, and Fe-SIH suggest that the manner in which iron is presented to cells influences its intracellular availability and utilization. Other studies support this concept. Although certain cells can accumulate ferritin iron from nitrilotriacetate, they may not use this form of iron to support cell proliferat i~n .~' In addition, Oria et a1" have shown that iron acquired from FeTF and iron acquired by phagocytosis were handled differently.
Obeid et alZZ cloned the 5'-terminal region of the human PKC-p gene from a human genomic library in EMBL-3 and determined coding sequences for 559 bp of the S'-flanking region.'* This area of the gene contains a number of potential cis-acting regulatory elements including an octamer-binding motif, Spl-, Apl-, and Ap2-binding sites, and E boxes. A 630-bp fragment extending from -587 to +43 was able to drive expression of a luciferase reporter gene in transient transfections of human hematopoietic cells. Deletion analysis showed that a fragment -11 1 to +43 bp was necessary and sufficient for promoter activity.
Analyses of these sequence data or of the additional PKC-0 sequence data reported by Niino et a14* showed no sequences with the features of previously described iron regulatory elements. Therefore, to locate iron-responsive DNA sequences within the PKC-,O promoter region, we developed a series of stably transfected cell lines bearing human PKC-0-luciferase fusion genes constructed with various portions of the PKC-P 5'-flanking region (Fig 1) . Treatment with FeTF of stable transfectants bearing PKC-@-luciferase constructs containing 2,200 bp of the human PKC-,O 5"flanking DNA showed a twofold to 2.5-fold increase of' luciferase activity and a corresponding increase of luciferase mRNA transcripts (Figs 7 and 8 and Table l) . Increases of luciferase activity and mRNA in FeTF-treated cultures were abolished by DF. Little or no increase in response to FeTF was observed in cells stably transfected with constructs containing 342 or 587 bp of the 5"flanking PKC-, B DNA. These data provide strong evidence that intracellular iron levels are importantly involved in regulation of PKC-0 expression and that the effect of iron is mediated by nucleotide sequences between -2,200 and -587 bp in the 5'-flanking region of the PKC-,O gene. It is of considerable interest that a recent report indicated that PKC mediated phosphorylation of the iron-responsive element binding protein during in vitro differentiation of HL-60 cells4' This observation documents an additional interface between PKC and iron regulation.
Other eukaryotic genes whose expression is regulated by iron include transferrin receptor and ferritin, but in these instances iron regulation occurs predominantly (but not exclusively) at a posttranscriptional level." However, we have recently shown that expression of the TRAP gene is regulated by iron in a manner similar to PKC-P.'X The mouse TRAP gene S'-flanking region has been sequenced to -I ,846 bp that encompasses the region involved in this iron-dependent regulation. No candidate iron response elements have been identified in this region, strongly suggesting that a novel iron-responsive transcription regulatory mechanism is involved. A similar mechanism may be involved in the iron responsiveness of the PKC-,B gene. Therefore, PKC-P and TRAP may represent a new class of iron-regulated genes.
